New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.
Oral Oncol. 2020 Jul;106:104659. doi: 10.1016/j.oraloncology.2020.104659. Epub 2020 Mar 21.
Oral Oncol. 2020.
PMID: 32209313
Free PMC article.
No abstract available.